XCF Global Continues New Rise Reno Planned Upgrade and Secures Forbearance Agreement Related to New Rise Renewables Reno Ground Lease
Agreement continues through January 1, 2027, subject to specified conditions, supporting New Rise’s planned upgrade
Agreement continues through January 1, 2027, subject to specified conditions, supporting New Rise’s planned upgrade
The Best Online Botox Course is AACM SEATTLE, WA / ACCESS Newswire / May 1,
The best Lower Eyelid Bag Removal in Raleigh, NC is by Dr. Jindal RALEIGH, NC
LOS ANGELES, CA / ACCESS Newswire / May 1, 2026 / A decade after Los
Board-certified orthodontist Dr. Tracy M. Liang introduces data-informed approach combining artificial intelligence with 3D imaging
MENLO PARK, Calif. & MIAMI–(BUSINESS WIRE)–Riverwood Capital, one of the leading investment firms solely dedicated
Delivers amended offer to TWO Board allowing stockholders to elect $12.00 per share in cash
The strategic move expands the company’s portfolio with Risk and Insurance solutions and strengthens its
TOKYO–(BUSINESS WIRE)–FUJIFILM Holdings Corporation — a global leader in imaging, healthcare, business innovation, and electronics
Irvine, California–(Newsfile Corp. – April 30, 2026) – Numerous concerned citizens have reported instances of
Phoenix, Arizona–(Newsfile Corp. – April 30, 2026) – Lotto Champ, an AI-powered software platform, has
With a platform designed to transform existing human-created assets into animated series and films, Nura
Top innovators from Disney, OpenAI, Pixar, Microsoft, and NVIDIA join IEEE-USA to inspire the next
Featuring dramatic series from Séries Plus, documentaries from Historia, Adult Swim’s flagship series, the DC
LONDON, APRIL 30, 2026 ― The Post Republic London’s Re-recording Mixer and Dialogue Editor Dan
STA VENERA, MALTA, APRIL 29, 2026 – CPI Media, a voluntary organization within the Missionary
FORT PIERCE, FL / ACCESS Newswire / April 30, 2026 / Twin Vee PowerCats Co.
Start a U.S. Company in Minutes Without Leaving Claude or Replit Founders can go from
The company is building the clinical intelligence and intervention layer to deliver whole-person cancer care
Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading